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Serum creatinine, as a marker of renal function, continues to be used in
spite of inaccuracies in its measurement as well as interference from other
factors. This has resulted in a multitude of formulae for calculating the
glomerularfiltrationrate(GFR).Morerecently,TheNationalKidneyFoundation
Dialysis Outcome Quality Initiative (K/DOQI) and the European Best Practice
GuidelinesrecommendedtheuseoftheModificationofDietinRenalDisease
(MDRD) study population for reporting estimated GFR (eGFR) [1-3]. This is in
preference to other formulae previously used to estimate renal function [4].
However, many of the shortcomings associated with eGFR calculation persist
and the search for an ideal marker of renal function continues.
The clearance of exogenous markers such as inulin (“gold standard”
method) and synthetic poly fructose solutions as well as non-radioactive
contrast media such as iohexol are considered as a more accurate evaluation
ofrenalfunction[5].Measurementofcreatininehassufferedinthepastfrom
inter-laboratory differences, some of which are attributed to differences in
calibration [6]. In addition, the measurement of creatinine by the most
common method (Jaffé) is subject to interference by chromogens such as
bilirubin, glucose and uric acid. Similarly, the enzymatic method is prone to
interferencebybilirubinandsomeantibiotics.Serumcreatininemeasurement
isalsoinfluencedbyfactorssuchascreatinineturnoverrate,tubularsecretion
of creatinine and creatinine production rate, which is reflected by the muscle
mass[7].Somestudieshaveshownthatadministrationofcimetidinetoblock
tubular secretion improves the reliability of GFR measurement [8]. Some
uniformitywithmeasurementhasbeenintroducedbyadoptionofacommon
calibration to isotope dilution mass spectrophotometry standard with
substantial improvement and traceability for creatinine measurements [9].
Larger muscle mass in Afro-Caribbeans and smaller muscle mass in South
Asians would show variable renal function compared with renal function
measured by gold standard methods if not corrected for muscle mass [7].
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Renal function deteriorates by 8 ml/min per
decade, in the ageing population, but there is also
wide intra-individual variability in this group [10-12].
Although the loss of renal parenchyma with ageing
accounts for this change, sarcopenia seen in the
elderly resulting in reduction in creatinine production
also influences renal function measurement [13].
Muscle  mass  declines  by  1-2%  per  year  after 
50 years. There is also an age-related reduction in
total body water, but a higher mass of body fat.
Muscle strength declines by 1.5% per year from age
50 to 60 years and after 60 years [14, 15]. Lower
creatinine levels have been reported in subjects with
vitamin D deficiency [16]. Vitamin D deficiency is
common among South Asians in the UK and this
may also increase the rate of loss of muscle mass
in this population along with a decrease in muscle
strength [16]. The prevalence of vitamin D deficiency
is also higher in the elderly. True renal function mea  -
surements are essential in the elderly population
where these and other age-related changes alter
the pharmacokinetics of pharma  ceutical agents
used for therapy or diagnosis leading to iatrogenic
toxicity. This may also be true for the group of
subjects who have been shown to have a smaller
muscle mass and higher body fat, such as those
from South Asian countries.
There  has  been  an  interest  in  using  low
molecular weight proteins such as β2-microglo  -
bulin and cystatin C as markers of renal function.
Cystatin C, aprotein that is produced by all the nucle  -
ated cells, has been shown to be superior to creati  -
nine as a maker of renal function with > 92% identity
with reference tests for GFR [17, 18]. Cystatin C 
level is independent of age, nutrition, diet (e.g.
exogenous creatinine from meat-rich diet), gender
and interference with creatinine measurement (e.g.
bilirubin) [18]. Equations have also been developed
using cystatin C measurements for estimating eGFR
[19]. However, cystatin C is not a perfect marker,
being influenced by infection, hypo- or hyper  -
thyroidism  or  drugs  such  as  corticosteroids,
angiotensin-converting  inhibitors,  calcineurin
inhibitors and co-trimoxazole [18]. Larger intra-
individual variation has also been reported with
cystatin C. Moreover, cystatin measurements are
not standardised and expensive compared with
creatinine measurement.
The inherent problems in using the different
prediction  equations  stem  from  the  problems
associated with the selected population used for
deriving the equation as well as the analytical
problems associated with measurement of creatinine
or cystatin C. The globally adopted MDRD equation
was derived from subjects who had renal impairment
and the GFR measured by iothalamate was 40 
±21 ml/min/1.73 m2 (mean ± SD) aged between 18
and 70 years (mean age ± SD: 51 ±13 years) [3].
Subjects less than 80% of ideal weight and above
160% of ideal weight were excluded [3]. The study
also did not recruit subjects of diverse ethnicity.
Therefore, extrapolating this prediction for measuring
eGFR to different ethnic and age groups should be
viewed with caution. In a screening study [20, 21]
involving a Gujarati population (currently n = 1267)
we noted a signi  ficant discrepancy in measurement
of eGFR in using different prediction equations in
relation to higher body fat (measured by 4 point
bioelectrical impedance) (unpublished results). The
MDRD formula also underestimates eGFR in those
with normal renal function as well as in the paediatric
age group, pregnant women, amputees, subjects
with very high body mass index and those aged 
> 70 years [3].
Recently, there has been an interest in assessing
the use of neutrophil gelatinase-associated lipocalin
(NGAL) (which functions as a shuttle for iron and
siderophores) as a marker of renal function [22].
NGAL is a small 25-kD protein released from renal
tubular cells. Several studies have reported that NGAL
may become a novel marker for impaired renal
function.  Serum  and  urine  NGAL  levels  show
impressive  predictive  power  for  progression  of
chronic kidney disease (CKD). The NGAL is released
from the renal tubule soon after damage even before
the circulating creatinine level rises. A recent study
has validated its specificity as an early predictor of
acute kidney injury [23]. Many of the factors that
influence creatinine mea  surements will not affect
the measurements of NGAL [23], with the possible
exception of pregnancy [24].
In this issue of the journal, Malyszko and col  -
leagues measured NGAL, kidney injury molecule-1
(KIM-1) and cystatin C in 412 subjects to assess the
prevalence of CKD [25]. Renal function was assessed
by the MDRD, Cockcroft-Gault and Chronic Kidney
Disease  Epidemiology  Collaboration  (CKD-EPI)
equations. The NGAL was the best predictor for
eGFR in those below and above 65 years. These
findings need to be evaluated using a gold standard
method. Their finding that diabetic patients had
a higher  level  of  NGAL  than  the  non-diabetic
patients but with very similar creatinine levels is
very interesting and may help predict future eGFR
values. They [25] also reported that the normo  -
tensive elderly had lower NGAL compared with
hypertensive subjects with similar serum creatinine
levels. Therefore, NGAL holds some promise as
a marker for predicting renal impairment and there
is potential for its use to assess reversal of renal
impairment after treatment. Another marker of
proximal tubular origin, KIM-1, has been shown to
be raised in ischaemic toxic injury to the kidney
[25]. The KIM-1 (a transmembrane protein with
immunoglobulin  like  mucin  domains  in  its
ectodomain)  is  completely  absent  in  kidneysArch Med Sci 4, August / 2011 567
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without any evidence of damage [24]. Urinary
excretion  of  KIM-1  has  been  shown  to  be  an
independent  predictor  of  long-term  graft
dysfunction after kidney transplant [26]. However,
evidence for its use in screening people with CKD
is lacking. Other markers may prove useful as
therapeutic targets, diagnostic tests or prognostic
tools to help prevent kidney damage [27, 28] but
they are beyond the scope of the present editorial. 
Accurate  assessment  of  renal  function  is
essential especially in those at high risk of deve  -
loping CKD, both young and old. Screening indi  -
viduals with the available prediction equations has
limitations. New markers of kidney injury such as
NGAL hold hopes for improved prediction of renal
function independently of age, ethnicity, gender,
muscle mass and body fat. More studies are needed
to assess the influence of ethnicity, various drugs
and changes in body composition in relation to this
marker. Until then, use of creatinine in various
equations predicting renal function will continue
for screening and monitoring.
References
1. National  Kidney  Foundation.  K/DQI  clinical  practice
guidelines for chronic kidney disease. Evaluation classi  -
fication and stratification. Kidney Disease Outcomes quality
Initiative. Am J Kidney Dis 2002; 39 (suppl 2): S1-266.
2. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D.
A more accurate method to estimate glomerular filtration
rate from serum creatinine. A new prediction equation.
Modification of Diet in Renal Disease Study Group. Ann
Intern Med 1999; 130: 461-70.
3. Section 1. Measurement of renal function, when to refer
and when start dialysis. European Best Practice Guidelines
Expert Group on Haemodialysis. Nephrol Dial Transplant
2002; 17 (Suppl 7): S7-15.
4. Lin J, Knight EL, Hogan ML, Singh AK. A comparison of
prediction equations for estimating glomerular filtration
rate in adults without kidney disease. J Am Soc Nephrol
2003; 14: 2573-80.
5. Grubb A. Replacing invasive with non-invasive methods
for estimating renal function. Clin Chem Lab Med 2009;
47 (Suppl.): S58.
6. Hallan S, Asberg A, Lindberg M, Johnson H. Validation of
the modification of diet in renal disease formula for
estimating GFR with special emphasis on calibration of
the serum creatinine assay. Am J Kidney Dis 2004; 44: 
84-93.
7. Sjosstrom PA, Odlind BG, Wolgast M. Extensive tubular
secretion and reabsorption of creatinine in humans.
Scand J Urol Nephrol 1988; 22: 129-31.
8. Roubenoff R, Drew H, Moyer M, Petri M, Whiting-O’Kee-
fe Q, Hellmann DB. Oral cimetidine improves the accuracy
and precision of creatinine clearance in lupus nephritis.
Ann Intern Med 1990; 113: 501-6.
9. Myers GL, Miller WG, Coresh J, et al. Recommendations
for improving serum creatinine measurement: a report
from the Laboratory Working Group of the National
Kidney Disease Education Program. Clin Chem 2006; 52:
5-18.
10. Kasiske BL, Umen AJ. The influence of age, sex, race, and
body habitus on kidney weight in humans. Arch Pathol
Lab Med 1986; 110: 55-60.
11. Davies DF, Shock NW. Age changes in glomerular filtration
rate, effective renal plasma flow, and tubular excretory
capacity in adult males. J Clin Invest 1950; 29: 496-507.
12. Rowe JW, Andres R, Tobin JD, Norris AH, Shock NW. The
effect of age on creatinine clearance in men: a cross-
sectional and longitudinal study. J Gerontol 1976; 31: 
155-63.
13. Evans WJ, Campbell WW. Sarcopenia and age related
changes in body composition and functional capacity. 
J Nutr 1993; 123: 465-8.
14. Baumgartner RN, Stauber PM, McHugh D, Koehler KM,
Garry  PJ.  Cross-sectional  age  differences  in  body
composition in persons 60+ years of age. J Gerontol 1995;
50: M307-16.
15. Volpi E, Nazemi R, Fujita S. Muscle tissue changes with
aging. Curr Opin Clin Nutr Metab Care 2004; 7: 405-10.
16. Fonseca V, Mohiuddin J, Weerakoon J, Boss M, Mikhailidis
DP, Dandona P . Plasma creatinine and creatinine clearance
in nutritional osteomalacia. Lancet 1984; 1: 1093-5.
17. Grubb A, Simonsen O, Sturfelt G Truedsson L, Tysell H.
Serum concentration of cystatin C, factor D and beta 2
microglobulin as a measure of glomerular filtration rate.
Acta Med Scand 1985; 218: 499-503.
18. Dharmidharka VR, Kwon C, Stevens G. Serum cystatin C
is superior to creatinine as a marker of kidney function;
a meta-analysis. Am J Kidney Dis 2002; 40: 221-6.
19. Maillard N, Mariat C, Bonneau C, et al. Cystatin C-based
equations  in  renal  transplantation:  moving  toward
a better glomerular filtration rate prediction? Trans  -
plantation 2008; 85: 1855.
20. Jain A, Persaud JW, Rao N, et al. Point of care testing is
appropriate for National Health Service health check. Ann
Clin Biochem 2011; 48: 159-65.
21. Rao N, Eastwood SV, Jain A, et al. Cardiovascular risk
assessment of South Asians in religious settings. Int J Clin
Pract 2011; in press.
22. Haase M, Bellomo R, Devarajan P, Schlattmann P, Haase-
Fielitz A. Accuracy of neutrophil gelatinase associated
lipocalin (NGAL) in diagnosis and prognosis in acute
kidney injury: a systematic review and meta-analysis. Am
J Kidney Dis 2009; 54: 1012-4.
23. Bolignano D, Donato V, Coppolino G, et al. Neutrophil
gelatinase-associated lipocalin (NGAL) as a marker of
kidney damage. Am J Kidney Dis 2008; 52: 595-609. 
24. Malyszko JS, Rams L, Drozdowska-Rams L, Malyszko J.
Serum  neutrophil  gelatinase-associated  lipocalin  as
a marker of kidney function in pregnancy – useful or
doubtful? Arch Med Sci 2010; 6: 744-7.
25. Malyszko J, Bachorzewska-Gajewska H, Malyszko J, Iaina-
Levin N, Kobus G, Dobrzycki S. Markers of kidney function
in the elderly in relation to new CKD-EPI formula for
estimation of GFR. Arch Med Sci 2011; 7: 658-64.
26. van Timmeren MM, van den Heuvel MC, Bailly V, Bakker
SJ,  vanGoor  H,  Stegeman  CA.  Tubular  kidney  injury
molecule-1 (KIM-1) in human renal disease. J Pathol 2007;
212: 209-17.
27. Gluba A, Banach M, Hannam S, Mikhailidis DP, Sako  -
wicz A, Rysz J. The role of Toll-like receptors in renal
diseases. Nat Rev Nephrol 2010; 6: 224-35.
28. Malyszko J, Zbroch E, Malyszko J, Mysliwiec M, Iaina A. The
cardio-renal-anaemia  syndrome  predicts  survival  in
peritoneally dialyzed patients. Arch Med Sci 2010; 6: 
539-44.